Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
2.
Eur J Nutr ; 58(8): 3121-3128, 2019 Dec.
Article in English | MEDLINE | ID: mdl-30523431

ABSTRACT

PURPOSE: Vitamin D deficiencies are common in elderly, which increases the risk for, e.g., bone fractures. Identification of determinants of vitamin D status may provide leads for specific deficiency prevention strategies. Although determinants of vitamin D status have been studied in various populations, this has not been examined in elderly that have a physically active lifestyle. METHODS: Vitamin D status of 450 physically active elderly who do not use vitamin D supplements was determined and information on possible determinants (demographic, dietary intake and physical activity) was collected around a prolonged four day walking event in July and analyzed in linear regression models. RESULTS: The average summertime serum 25(OH)D concentration was 88.8 ± 22.4 nmol/L. Only 2% of the participants had a 25(OH)D concentration below 50 nmol/L. Dietary intake of vitamin D was 4.0 ± 1.9 µg/day, and the participants spent 12.4 ± 8.6 h/week on outdoor activities. In the multivariate model, lower age (= - 0.48, 95% CI - 0.80 to - 0.16), lower BMI (= - 0.86, 95% CI - 1.62 to - 0.10), being a moderate to high drinker versus a non-drinker (= 7.97, 95% CI 0.43-15.51) and more outdoor physical activity (= 0.25, 95% CI 0.01-0.50) were significantly associated with higher 25(OH)D concentrations. CONCLUSIONS: In physically active elderly, vitamin D status was very high in summertime, with few deficiencies, suggesting that elderly with a physical active lifestyle might not necessarily need supplements during the summer period. Lower age, lower BMI, higher alcohol intake and more outdoor physical activity had a significant association with vitamin D status.


Subject(s)
Exercise/physiology , Geriatric Assessment/methods , Life Style , Vitamin D Deficiency/epidemiology , Aged , Aged, 80 and over , Female , Geriatric Assessment/statistics & numerical data , Humans , Male , Netherlands/epidemiology , Vitamin D/blood , Vitamin D Deficiency/blood
3.
Int J Obes (Lond) ; 38(3): 470-3, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23958793

ABSTRACT

Polyphenolic compounds, such as resveratrol, have recently received widespread interest because of their ability to mimic effects of calorie restriction. The objective of the present study was to gain more insight into the effects of 30 days resveratrol supplementation on adipose tissue morphology and underlying processes. Eleven healthy obese men were supplemented with placebo and resveratrol for 30 days (150 mg per day), separated by a 4-week washout period in a double-blind randomized crossover design. A postprandial abdominal subcutaneous adipose tissue biopsy was collected to assess adipose tissue morphology and gene expression using microarray analysis. Resveratrol significantly decreased adipocyte size, with a shift toward a reduction in the proportion of large and very-large adipocytes and an increase in small adipocytes. Microarray analysis revealed downregulation of Wnt and Notch signaling pathways and upregulation of pathways involved in cell cycle regulation after resveratrol supplementation, suggesting enhanced adipogenesis. Furthermore, lysosomal/phagosomal pathway and transcription factor EB were upregulated reflecting an alternative pathway of lipid breakdown by autophagy. Further research is necessary to investigate whether resveratrol improves adipose tissue function.


Subject(s)
Adipocytes/drug effects , Adipocytes/metabolism , Adipose Tissue/metabolism , Enzyme Inhibitors/therapeutic use , Obesity/drug therapy , Stilbenes/therapeutic use , Adipogenesis/drug effects , Adipose Tissue/drug effects , Adult , Aged , Cross-Over Studies , Double-Blind Method , Gene Expression Profiling , Humans , Male , Middle Aged , Obesity/genetics , Obesity/metabolism , Receptors, Notch/drug effects , Receptors, Notch/metabolism , Resveratrol , Signal Transduction/drug effects , Treatment Outcome , Wnt Signaling Pathway/drug effects
4.
Diabet Med ; 30(10): 1214-8, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23663119

ABSTRACT

AIMS: Resveratrol, a natural polyphenolic compound produced by various plants (e.g. red grapes) and found in red wine, has glucose-lowering effects in humans and rodent models of obesity and/or diabetes. The mechanisms behind these effects have been suggested to include resveratrol-induced secretion of the gut incretin hormone glucagon-like peptide-1. We investigated postprandial incretin hormone and glucagon responses in obese human subjects before and after 30 days of resveratrol supplementation. METHODS: Postprandial plasma responses of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide and glucagon were evaluated in 10 obese men [subjects characteristics (mean ± standard error of the mean): age 52 ± 2 years; BMI 32 ± 1 kg/m(2), fasting plasma glucose 5.5 ± 0.1 mmol/l] who had been given a dietary supplement of resveratrol (Resvida(®) 150 mg/day) or placebo for 30 days in a randomized, double-blind, crossover design with a 4-week washout period. At the end of each intervention period a standardized meal test (without co-administration of resveratrol) was performed. RESULTS: Resveratrol supplementation had no impact on fasting plasma concentrations or postprandial plasma responses (area under curve values) of glucose-dependent insulinotropic polypeptide (11.2 ± 2.1 vs. 11.8 ± 2.2 pmol/l, P = 0.87; 17.0 ± 2.2 vs. 14.8 ± 1.6 min × nmol/l, P = 0.20) or glucagon-like peptide-1 (15.4 ± 1.0 vs. 15.2 ± 0.9 pmol/l, P = 0.84; 5.6 ± 0.4 vs. 5.7 ± 0.3 min × nmol/l, P = 0.73). Resveratrol supplementation significantly suppressed postprandial glucagon responses (4.4 ± 0.4 vs. 3.9 ± 0.4 min × nmol/l, P = 0.01) without affecting fasting glucagon levels (15.2 ± 2.2 vs. 14.5 ± 1.5 pmol/l, P = 0.56). CONCLUSIONS: Our data suggest that 30 days of resveratrol supplementation does not affect fasting or postprandial incretin hormone plasma levels in obese humans, but suppresses postprandial glucagon responses.


Subject(s)
Antioxidants/therapeutic use , Blood Glucose/drug effects , Glucagon/drug effects , Obesity/blood , Stilbenes/therapeutic use , Blood Glucose/metabolism , Cross-Over Studies , Dietary Supplements , Double-Blind Method , Fasting , Gastric Inhibitory Polypeptide/blood , Gastric Inhibitory Polypeptide/drug effects , Glucagon/blood , Glucagon-Like Peptide 1/blood , Glucagon-Like Peptide 1/drug effects , Humans , Incretins/blood , Male , Middle Aged , Obesity/complications , Obesity/drug therapy , Postprandial Period , Resveratrol , Time Factors , Treatment Outcome
5.
Nutr Diabetes ; 1: e11, 2011 Jul 11.
Article in English | MEDLINE | ID: mdl-23449423

ABSTRACT

OBJECTIVE: In conditions of continuous high-fat (HF) intake, the degree of saturation of the fatty acids (FAs) in the diet might have a crucial role in the onset of obesity and its metabolic complications. In particular, the FA composition of the diet might influence the storage form of lipids inside skeletal muscle. The aim of the present study was to examine whether the FA composition of HF diets differentially affects weight gain and accumulation of myocellular triacylglycerol (TAG) and diacylglycerol (DAG). Furthermore, we examined whether the FA composition of the diet was reflected in the composition of the myocellular lipid intermediates. DESIGN: C57Bl6 mice were fed HF diets (45% energy) mainly containing palm oil (PO), cocoa butter (CB), olive oil (OO) or safflower oil (SO; n=6 per group) for 8 weeks. A low-fat diet (10% energy, PO) was used as control. Body weight was monitored weekly. At the end of the dietary intervention, myocellular TAG and DAG content and profiles were measured. RESULTS: We here show that HF_CB prevented weight gain after 8 weeks of HF feeding. Furthermore, the HF diet rich in SO prevented the accumulation of both myocellular TAG and DAG. Interestingly, the FA composition of DAG and TAG in skeletal muscle was a reflection of the dietary FA composition. CONCLUSION: Already after a relatively short period, the dietary FA intake relates to the FA composition of the lipid metabolites in the muscle. A diet rich in polyunsaturated FAs seems to prevent myocellular lipid accumulation.

SELECTION OF CITATIONS
SEARCH DETAIL
...